Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedANDA213706-001

ACETAZOLAMIDE

Carbonic anhydrase inhibitors

Manufacturer: TORRENT

FDA Approval: 26/01/2024

Route: ORAL · TABLET

Active Ingredients

ACETAZOLAMIDE 125MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ACETAZOLAMIDE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.